NCT03816345 2026-03-18
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
Clinical Trials
30 trialsNCT07289399 2025-12-17
Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?
Cairo University
Phase NA Recruiting
NCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
NCT06281106 2025-04-02
TYPP
Centre Hospitalier Universitaire Vaudois
Phase 2/3 Terminated
NCT03721172 2024-05-29
ADVANCE
Amgen
Phase 3 Completed
NCT00585650 2023-08-18
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet
University of California, Irvine
Phase 1/2 Completed
NCT03656627 2023-02-15
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
Phase 1 Terminated
NCT04571567 2022-04-11
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT02762955 2021-09-08
CALYPSO
Biocad
Phase 3 Completed
NCT00885196 2020-12-22
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Novartis
Phase 2 Completed
NCT01490632 2019-09-27
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT00924950 2019-04-18
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
University of California, San Francisco
Phase 4 Terminated
NCT01815424 2019-04-16
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01961609 2019-03-18
SIGNATURE
Novartis
Phase 3 Completed
NCT01582932 2019-01-22
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
Mayne Pharma International Pty Ltd
Phase 1 Completed
NCT01186744 2018-12-26
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT01241591 2018-12-26
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT03424629 2018-04-20
Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
Tianjin Ever Union Biotechnology Co., Ltd.
Phase 1 Unknown
NCT02196701 2018-03-19
CLEAR
AbbVie
Phase 3 Completed
NCT01053819 2018-02-23
Can We Miss Pigmented Lesions in Psoriasis Patients?
University of Alabama at Birmingham
Phase 4 Completed
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT00932113 2017-08-31
MOA
Tufts Medical Center
Phase 4 Completed
NCT01163253 2017-06-26
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Terminated
NCT01313221 2017-03-15
REFINE
Amgen
Phase 3 Completed
NCT01831466 2015-11-25
Tofacitinib Ointment For Chronic Plaque Psoriasis
Pfizer
Phase 2 Completed
NCT01519089 2015-08-13
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Pfizer
Phase 3 Completed
NCT01276639 2014-09-19
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT00824889 2014-08-29
Exploratory Study of Natural Killer Cells in Human Skin
Assistance Publique Hopitaux De Marseille
Phase NA Completed
NCT00111449 2013-05-15
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Amgen
Phase 3 Completed
NCT01077882 2012-07-06
OnderHUIDs
University Hospital, Ghent
Phase 4 Completed